Concepedia

Publication | Open Access

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls

DOIFull Paper Access

149

Citations

33

References

2017

Year

Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, Peggy Taylor, Leslie M. Shaw, John Q. Trojanowski, Andy Singleton, Mark Frasier, Kenneth Marek, Douglas Galasko
Neurology

Abstract

These core CSF biomarkers remained stable over 6 and 12 months in patients with early PD and HC. PD medication use may influence CSF α-syn. Novel biomarkers are needed to better profile progressive neurodegeneration in PD.

References

YearCitations

Page 1